Univest
Univest
  • Markets

ABH Healthcare Initial Public Offering Day 2: Subscription Status, Price Band Rs 96 to 102 and Key Dates for August 25, 2026

  • August 25, 2026
  • Posted by: Neeraj Pandey
  • Category: IPO
No Comments
ABH Healthcare Initial Public Offering Day 2: Subscription Status, Price Band Rs 96 to 102 and Key Dates for August 25, 2026

ABH Healthcare IPO Day 2: Rs 96 to 102, lot 1,200 shares, min Rs 2,44,800. Open August 24, 2026 to August 26, 2026. Allotment August 27 or 28, 2026. Listing September 1, 2026.

Quick Answer

Today is Day 2 of the ABH Healthcare initial public offering subscription. The issue opened on August 24, 2026 at a price band of Rs 96 to 102 per share, with a lot size of 1,200 shares and a minimum investment of Rs 2,44,800. The ABH Healthcare initial public offering closes on August 26, 2026. Allotment is expected on August 27 or 28, 2026 and listing on NSE SME is expected on September 1, 2026. Investors who have not yet applied should review the company’s RHP on SEBI EDGAR before applying on the remaining subscription days.

Table of Contents

Toggle
  • ABH Healthcare Initial Public Offering Day 2: Where Things Stand
  • How to Apply on Day 2 of ABH Healthcare Initial Public Offering
  • Business Overview
  • Grey Market Premium: What Investors Should Know
  • Conclusion: ABH Healthcare Initial Public Offering Day 2
  • Frequently Asked Questions
    • What day is the ABH Healthcare initial public offering on August 25?
    • Can I still apply for the issue on Day 2?
    • What is this issue price band?
    • What is this issue allotment date?
    • What is this issue listing date?
    • Is there a GMP for the issue on Day 2?
    • What is ABH Healthcare’s business?

ABH Healthcare Initial Public Offering Day 2: Where Things Stand

Today is Day 2 of 3 subscription days for the ABH Healthcare initial public offering. The issue opened on August 24, 2026 and will close on August 26, 2026. Day 2 typically shows early institutional and HNI (High Net Worth Individual) activity as larger investors begin placing their bids, while QIBs (Qualified Institutional Buyers) tend to submit bids primarily on Day 3 (the final day) of a subscription window. The ABH Healthcare initial public offering subscription data for Day 2 will be available on the BSE and NSE exchange portals throughout the day.

Parameter Detail
Issue Name ABH Healthcare Initial Public Offering
Day 2 Date August 25, 2026 (Today)
IPO Open Date August 24, 2026
IPO Close Date August 26, 2026 (tomorrow, last day)
Price Band Rs 96 to 102 per share
Lot Size 1,200 shares
Minimum Investment (Retail) Rs 2,44,800
Issue Size Rs 34.97 crore
Exchange NSE SME
Allotment Date August 27 or 28, 2026
Listing Date September 1, 2026
Registrar Bigshare Services

Click Here and Get Free Investment Predictions

How to Apply on Day 2 of ABH Healthcare Initial Public Offering

If you have not yet applied and have reviewed the company’s financials and risk factors from the Red Herring Prospectus (RHP), today is a good day to submit your application. Apply through your Demat account using ASBA or UPI payment on any SEBI-registered broker platform. Select the ABH Healthcare initial public offering in the IPO section, bid at the cut-off price (Rs 102 upper band) or within the price band, and confirm via UPI block or ASBA mandate. Applying at the cut-off price maximises allotment probability.

Day 2 applications are equally valid as Day 1 applications. There is no advantage to applying on any specific day within the subscription window, as allotment is determined after the subscription closes and all bids are processed simultaneously.

Screen Healthcare and Hospital Services Sector Peers on Univest for Valuation Context

Business Overview

ABH Healthcare is a Punjab-based specialised tertiary care healthcare company operating the Anil Baghi Hospital brand with a 150-bed capacity in Tier 3 cities. It offers 25 medical specialties including cardiac sciences, neurology, gastroenterology, and laparoscopic surgery. Full financial details, promoter background, objects of the issue, and risk factors are available in the ABH Healthcare initial public offering Red Herring Prospectus filed with SEBI on the EDGAR portal. Review the RHP thoroughly before deciding to subscribe on Day 2 or on the remaining days before August 26, 2026.

Grey Market Premium: What Investors Should Know

A Grey Market Premium (GMP) may appear on unofficial platforms like IPOWatch or Investorgain. GMP is unofficial, not sanctioned by SEBI, and is frequently an inaccurate predictor of actual listing prices. Day 2 GMP figures can change significantly through the remaining subscription days and should never be the primary basis for a subscription decision. Always evaluate this issue on the basis of the company’s fundamentals from the RHP.

Download the Univest iOS App or Univest Android App to track ABH Healthcare subscription status and allotment updates live.

Conclusion: ABH Healthcare Initial Public Offering Day 2

Day 2 of the ABH Healthcare initial public offering is underway today. The issue closes on August 26, 2026. Price band is Rs 96 to 102 with a lot size of 1,200 shares. Allotment is expected on August 27 or 28, 2026 and listing on NSE SME is expected on September 1, 2026. GMP is unofficial; evaluate the issue on fundamentals from the RHP. Consult a SEBI-registered investment adviser before applying.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions

What day is the ABH Healthcare initial public offering on August 25?

Ans. August 25 is Day 2 of 3 subscription days for this issue. The issue opened on August 24, 2026 and closes on August 26, 2026. Allotment is expected on August 27 or 28, 2026 and listing on NSE SME on September 1, 2026.

Can I still apply for the issue on Day 2?

Ans. Yes, you can still apply on Day 2 today. The subscription window remains open until August 26, 2026. Apply through your Demat account using ASBA or UPI on any SEBI-registered broker platform. Day 2 applications are equally valid as Day 1.

What is this issue price band?

Ans. This issue price band is Rs 96 to 102 per share. The lot size is 1,200 shares with a minimum investment of Rs 2,44,800 for retail investors.

What is this issue allotment date?

Ans. This issue allotment is expected to be finalised on August 27 or 28, 2026. Shares will be credited to successful applicants’ Demat accounts within 1 to 2 business days.

What is this issue listing date?

Ans. Shares are expected to list on NSE SME on September 1, 2026. The actual listing price on the exchange on that date is the only valid reference for post-allotment decisions.

Is there a GMP for the issue on Day 2?

Ans. GMP for this issue may appear on unofficial platforms like IPOWatch or Investorgain. GMP is not sanctioned by SEBI and is frequently inaccurate as a predictor of listing prices. Do not base your subscription decision on Day 2 GMP. Evaluate using the company’s fundamentals from the RHP.

What is ABH Healthcare’s business?

Ans. ABH Healthcare is a Punjab-based specialised tertiary care healthcare company operating the Anil Baghi Hospital brand with a 150-bed capacity in Tier 3 cities. It offers 25 medical specialties including cardiac sciences, neurology, gastroenterology, and laparoscopic surgery. Full details are in the RHP on SEBI EDGAR.



IPO
Author: Neeraj Pandey
Neeraj Pandey is a Financial Content Writer at Univest, covering Indian equity markets with a specialisation in quarterly earnings previews and analyst consensus analysis. His published work tracks Q4 FY26 results across 10+ sectors — from IT heavyweights like Infosys and TCS to PSUs like Coal India and Balmer Lawrie, and mid-caps like Neuland Laboratories, MCX, and Whirlpool of India. His writing approach is data-first: every article anchors on NSE/BSE filings, analyst consensus estimates (revenue, PAT, EBITDA margins), 52-week price context, and YoY/QoQ comparisons — giving retail investors the same structured framework institutional desks use before an earnings event. He combines SEO-optimised structure with rigorous data sourcing, ensuring each preview ranks for investor search intent while meeting SEBI editorial standards. All articles are reviewed by Univest's in-house equity research team, led by Ankit Jaiswal, Senior Equity Research Analyst, to meet SEBI editorial standards.

Leave a Reply Cancel reply